Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (162)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
28
0.640
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1060
0.540
 Why?
Leukemia, Myeloid, Acute
4
2010
192
0.430
 Why?
Osteosarcoma
2
2016
37
0.360
 Why?
von Willebrand Diseases
1
2009
21
0.350
 Why?
Hematology
1
2009
26
0.350
 Why?
Sclerotherapy
2
2020
47
0.340
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.300
 Why?
Hemophilia B
1
2007
4
0.300
 Why?
Vascular Malformations
2
2020
101
0.300
 Why?
Hemostasis, Surgical
1
2007
12
0.300
 Why?
Blood Coagulation Factors
1
2007
19
0.300
 Why?
Enoxaparin
1
2007
25
0.300
 Why?
Antineoplastic Agents
4
2016
1300
0.300
 Why?
Blood Loss, Surgical
1
2007
79
0.290
 Why?
Child, Preschool
13
2020
4161
0.290
 Why?
Venous Thrombosis
1
2007
102
0.270
 Why?
Cyclosporine
1
2005
66
0.270
 Why?
Cisplatin
3
2016
351
0.260
 Why?
Blood Coagulation Disorders
2
2020
37
0.260
 Why?
Hemostasis
2
2020
55
0.260
 Why?
Leukemia
1
2005
69
0.260
 Why?
Cladribine
1
2004
4
0.250
 Why?
Bone Regeneration
2
2016
71
0.250
 Why?
Histiocytosis, Langerhans-Cell
1
2004
26
0.240
 Why?
Retinal Neoplasms
1
2003
13
0.230
 Why?
Retinoblastoma
1
2003
16
0.230
 Why?
Infant
11
2018
3832
0.220
 Why?
Neoplasms, Second Primary
1
2003
77
0.220
 Why?
Child
13
2020
7372
0.200
 Why?
Bone Neoplasms
1
2003
193
0.200
 Why?
Neoplasms
2
2012
1321
0.190
 Why?
Thrombelastography
1
2020
28
0.190
 Why?
Adolescent
11
2020
6896
0.180
 Why?
Bleomycin
1
2018
37
0.160
 Why?
Down Syndrome
3
2008
100
0.150
 Why?
Antibiotics, Antineoplastic
1
2018
85
0.150
 Why?
Osteogenesis, Distraction
2
2016
72
0.150
 Why?
Piperazines
2
2016
115
0.140
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
9
0.140
 Why?
Leukemia, Myeloid
2
2008
54
0.140
 Why?
Disease-Free Survival
5
2010
488
0.130
 Why?
Humans
20
2020
54304
0.130
 Why?
Remission Induction
4
2011
222
0.130
 Why?
Imidazoles
1
2016
143
0.130
 Why?
Male
13
2020
27335
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
105
0.120
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
40
0.120
 Why?
Doxorubicin
2
2005
259
0.110
 Why?
Survival Analysis
4
2010
736
0.110
 Why?
Cord Blood Stem Cell Transplantation
1
2011
5
0.100
 Why?
Sarcoma, Myeloid
1
2011
22
0.100
 Why?
Heart Neoplasms
1
2011
33
0.100
 Why?
Neutropenia
1
2012
120
0.100
 Why?
Core Binding Factors
1
2010
2
0.090
 Why?
Treatment Outcome
7
2018
5609
0.090
 Why?
Proto-Oncogene Proteins c-kit
1
2010
35
0.090
 Why?
Entamoebiasis
1
2009
2
0.090
 Why?
Liver Abscess
1
2009
4
0.090
 Why?
Diarrhea, Infantile
1
2009
5
0.090
 Why?
Listeriosis
1
2009
7
0.090
 Why?
Anemia, Aplastic
1
2009
12
0.090
 Why?
Platelet Transfusion
1
2009
32
0.090
 Why?
Female
10
2020
28457
0.090
 Why?
Acute Lung Injury
1
2009
19
0.080
 Why?
Histocompatibility Testing
1
2008
12
0.080
 Why?
HLA Antigens
1
2008
56
0.080
 Why?
Abdominal Pain
1
2009
84
0.080
 Why?
Young Adult
5
2020
4313
0.080
 Why?
Bone Marrow Transplantation
1
2008
149
0.080
 Why?
Hospitals, Pediatric
1
2009
270
0.080
 Why?
Adult
7
2020
14189
0.080
 Why?
Retrospective Studies
5
2018
6462
0.070
 Why?
Infusions, Intravenous
2
2004
231
0.070
 Why?
Cardiomyopathies
1
2008
131
0.070
 Why?
Mitolactol
1
2005
2
0.070
 Why?
GATA1 Transcription Factor
1
2005
7
0.070
 Why?
Leukocyte Count
1
2005
77
0.070
 Why?
Karyotyping
1
2005
92
0.070
 Why?
Tamoxifen
1
2005
61
0.070
 Why?
Gene Expression Regulation, Neoplastic
2
2006
868
0.060
 Why?
Heart
1
2008
361
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.060
 Why?
Immunosuppressive Agents
1
2005
248
0.060
 Why?
Humerus
1
2003
21
0.060
 Why?
Proto-Oncogene Proteins
1
2004
169
0.060
 Why?
Arkansas
1
2009
2097
0.060
 Why?
Tibia
1
2003
117
0.060
 Why?
Methotrexate
1
2003
73
0.060
 Why?
Topotecan
1
2002
19
0.050
 Why?
Survivors
1
2003
137
0.050
 Why?
Mutation
2
2010
1504
0.050
 Why?
Blood Coagulation Tests
1
2020
23
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
435
0.050
 Why?
Blood Flow Velocity
1
2020
114
0.050
 Why?
Blood Coagulation
1
2020
69
0.050
 Why?
Dose-Response Relationship, Drug
1
2004
1476
0.050
 Why?
Prognosis
3
2012
2126
0.040
 Why?
Follow-Up Studies
2
2018
2389
0.040
 Why?
Mice, Inbred C57BL
2
2016
2002
0.040
 Why?
Hemorrhage
1
2020
209
0.040
 Why?
Gene Expression Profiling
1
2004
1141
0.040
 Why?
Daunorubicin
2
2008
12
0.040
 Why?
Cytarabine
2
2006
40
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
219
0.030
 Why?
Mice, Nude
1
2016
284
0.030
 Why?
Random Allocation
1
2016
308
0.030
 Why?
Acute Disease
2
2008
403
0.030
 Why?
Cluster Analysis
2
2005
244
0.030
 Why?
Prospective Studies
2
2012
2604
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
474
0.030
 Why?
Interleukin-3
1
2012
13
0.030
 Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.030
 Why?
Calcitonin
1
2012
38
0.030
 Why?
Protein Precursors
1
2012
47
0.030
 Why?
Interleukin-8
1
2012
99
0.030
 Why?
Interleukin-10
1
2012
106
0.030
 Why?
ROC Curve
1
2012
259
0.030
 Why?
Fatal Outcome
1
2011
225
0.020
 Why?
Mice, Knockout
1
2013
928
0.020
 Why?
Intensive Care Units
1
2012
232
0.020
 Why?
Interleukin-6
1
2012
315
0.020
 Why?
Exons
1
2010
105
0.020
 Why?
Pilot Projects
1
2012
805
0.020
 Why?
Opportunistic Infections
1
2009
58
0.020
 Why?
Animals
2
2016
14402
0.020
 Why?
Echocardiography
1
2011
392
0.020
 Why?
Mitoxantrone
1
2008
11
0.020
 Why?
Translocation, Genetic
1
2010
287
0.020
 Why?
Hospitalization
1
2012
702
0.020
 Why?
Proportional Hazards Models
1
2008
430
0.020
 Why?
Recurrence
1
2008
692
0.020
 Why?
Prevalence
1
2010
1026
0.020
 Why?
Immunophenotyping
1
2006
117
0.020
 Why?
Genetic Predisposition to Disease
1
2010
571
0.020
 Why?
Nucleic Acid Hybridization
1
2005
54
0.020
 Why?
Luciferases
1
2005
57
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1222
0.020
 Why?
DNA Primers
1
2005
225
0.020
 Why?
Cell Membrane
1
2006
279
0.020
 Why?
Middle Aged
1
2020
13076
0.020
 Why?
Diagnosis, Differential
1
2009
1143
0.020
 Why?
Tumor Cells, Cultured
1
2005
477
0.020
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.020
 Why?
Transfection
1
2005
399
0.020
 Why?
fms-Like Tyrosine Kinase 3
1
2004
16
0.020
 Why?
Benzamides
1
2004
54
0.020
 Why?
Magnetic Resonance Imaging
1
2011
1616
0.020
 Why?
Sensitivity and Specificity
1
2006
922
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
674
0.010
 Why?
Risk Assessment
1
2008
1361
0.010
 Why?
Risk Factors
1
2012
3934
0.010
 Why?
Pyrimidines
1
2004
196
0.010
 Why?
DNA Helicases
1
2004
132
0.010
 Why?
Nuclear Proteins
1
2004
253
0.010
 Why?
Mice
1
2013
6428
0.010
 Why?
Time Factors
1
2008
3207
0.010
 Why?
DNA-Binding Proteins
1
2004
462
0.010
 Why?
Predictive Value of Tests
1
2004
1044
0.010
 Why?
Drug Administration Schedule
1
2002
401
0.010
 Why?
Transcription Factors
1
2004
622
0.010
 Why?
Infant, Newborn
1
2006
2923
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (162) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department